Home | Contact us | Investors  
 
 

 Select Projects on metabolomics

  • Metabolic fingerprinting of TB strains in response to drug candidates.
    Avesthagen is providing services in this area to large pharma companies. For this pharmaceutical company involved in the study of tuberculosis, quantitative, targeted metabolite fingerprinting analysis of key metabolites and pathway intermediates in microbial cultures in response to treatment with antibiotics is being carried out.

     

  • Glucose uptake assays to screen for anti-diabetic compounds.
    At Avesthagen, compounds are being screened for anti-diabetic activity using primary hepatocyte cultures and 3T3-L1 fibroblast/adipocyte cell lines.